Invivyd (IVVD) Free Cash Flow (2021 - 2025)
Invivyd (IVVD) reported Free Cash Flow of -$15.5 million for Q4 2025, up 58.9% on a YoY basis from -$9.7 million in Q4 2024, and down 87.33% quarter-over-quarter from -$8.2 million in Q3 2025.
Invivyd (IVVD) Free Cash Flow (2021 - 2025) Analysis & Trends
Invivyd has reported Free Cash Flow for 5 years, with the latest figure at -$15.5 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 58.9% year-over-year to -$15.5 million; the trailing twelve-month figure through Dec 2025 stood at -$58.3 million (up 65.84% YoY), and the FY2025 full-year result was -$58.3 million, up 65.84% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$15.5 million, down from -$8.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$8.2 million in Q3 2025, with the low at -$73.3 million in Q4 2021.
- Historically, Free Cash Flow has averaged -$40.5 million across 5 years, with a median of -$41.3 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 148.72% — and 2025, when it surged 79.91%.
- Invivyd's Free Cash Flow stood at -$73.3 million in 2021, then surged by 33.67% to -$48.6 million in 2022, then fell by 21.86% to -$59.2 million in 2023, then jumped by 36.52% to -$37.6 million in 2024, then surged by 58.9% to -$15.5 million in 2025.
- The last three Free Cash Flow figures came in at -$15.5 million (Q4 2025), -$8.2 million (Q3 2025), and -$13.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | -15.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.46 Mn |
| Dec 31, 2025 | -15.46 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Mar 31, 2025 | -21.27 Mn |
| Mar 31, 2025 | -21.27 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Mar 31, 2024 | -50.35 Mn |
| Mar 31, 2024 | -50.35 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Sep 30, 2023 | -35.35 Mn |
| Sep 30, 2023 | -35.35 Mn |